Sign in
Enrolling by invitationNo phase

Suzetrigine for pain relief after thumb joint replacement surgery

Tests suzetrigine for pain after thumb joint surgery in people with thumb osteoarthritis.

Key facts

Who runs it
Rothman Institute Orthopaedics
Where
Philadelphia, United StatesSee the site
Trial code
Registry title
Journavx to Treat Pain After Thumb Basal Joint Arthroplasty
Status
Enrolling by invitation
People taking part
100 people, planned
Started
21 Jul 2026
Expected to end
31 Dec 2028
Type of study
Observational
Treatments tested
  • suzetrigine 100mg
  • Acetaminophen
Record updated
23 July 2026

Who can take part

The trial is looking for adults having thumb basal joint replacement surgery (arthroplasty). It tests suzetrigine with acetaminophen for pain after surgery.

Age
40 to 80 years
Sex
All sexes
Disease stage
People having thumb basal joint arthroplasty (BJA).
Earlier treatment
People who had surgery on the study hand within the last 6 months cannot join. People now using a prescription pain medicine other than the study medicines cannot join.
Main reasons for not taking part
  • Past substance abuse or long-term opioid use
  • Allergy to acetaminophen, oxycodone or suzetrigine
  • Severe kidney or liver problems, eGFR less than 15 ml/min/1.73m^2, Child-Pugh Class C, liver failure, active hepatitis or past kidney transplant
  • Pregnant, planning pregnancy or breastfeeding
  • Use of strong or moderate CYP3A inhibitors or inducers, or medicines known to interact with suzetrigine
Show the full registry criteria (16)Hide the full registry criteria

Who can take part

  • Aged 40-80 years
  • Undergoing thumb basal joint arthroplasty (BJA)
  • Able to provide informed consent
  • Willing to comply with the study procedures

Who cannot take part

  • Has had prior surgery on the study hand within the last 6 months
  • Use of strong or moderate CYP3A inhibitors or inducers, or medications known to interact with suzetrigine
  • Currently using a prescription pain medication other study medications
  • History of substance abuse or chronic opioid use
  • Known allergies to acetaminophen, oxycodone, or suzetrigine
  • History of kidney transplant
  • History of liver failure
  • Active hepatitis that can adversely influence hepatic function
  • Severe renal or hepatic dysfunction
  • Estimated glomerular filtration rate less than 15 ml/min/1.73m\^2
  • Child-Pugh Class C
  • Is currently pregnant, planning to be pregnant, or breastfeeding

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Thumb basal joint osteoarthritis or postoperative pain or joint replacement

Where in United States

  • Rothman Orthopaedic InstitutePhiladelphia, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The purpose of this study is to find out how well suzetrigine, a newly FDA-approved non-opioid pain medication, works to relieve pain after thumb basal joint replacement surgery. The researchers believe that suzetrigine may provide effective pain relief during recovery without the use of opioid medications.

The group in the trial

  • Participants undergoing thumb Basal Joint Replacement Surgery

    Participants undergoing thumb Basal Joint Replacement Surgery receive suzetrigine (100 mg loading dose followed by 50 mg every 12 hours for 5 days) in combination with acetaminophen (Tylenol).

    Treatment: suzetrigine 100mg and Acetaminophen

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Single-Arm Open-Label Trial Evaluating the Efficacy of Suzetrigine (Journavx) in Multimodal Postoperative Pain Management Following Thumb Basal Joint Arthroplasty
Plain-language title
Suzetrigine for pain relief after thumb joint replacement surgeryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT07723352, who can take part
Record updated
23 July 2026